1 research outputs found
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
Purpose: This phase III study compared docetaxel and doxorubicin in patients with metastatic breast cancer who had received previous alkylating agent-containing chemotherapy